PureTech Health plc
NASDAQ:PRTC · NASDAQ Global Market
+$0.45 today
Vol 0.00M · Avg 0.01M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-1.09%
Period High
$19.84
Period Low
$14.50
Latest
$17.31
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alumis Inc. Common Stock
NASDAQ:ALMS
$2.85B
Solid Biosciences Inc.
NASDAQ:SLDB
$590.17M
Neurogene Inc.
NASDAQ:NGNE
$496.34M
Autolus Therapeutics plc
NASDAQ:AUTL
$409.86M
Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
$350.94M
Benitec Biopharma Inc.
NASDAQ:BNTC
$316.28M
Lineage Cell Therapeutics, Inc.
AMEX:LCTX
$304.14M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$271.13M
Quantum-Si incorporated
NASDAQ:QSI
$193.17M
ADC Therapeutics S.A.
NYSE:ADCT
$138.00M
What is the latest PRTC filing?
The latest filing shown is F-6 POS dated May 22, 2026.
How many recent filings does PRTC have?
Intrinsic Alpha currently shows 20 recent filings for PRTC.
Explore More
Continue the stock analysis
Jump to another research area for this company.